Related content

Mutations in non-structural 5A and rapid viral response to pegylated interferon-α-2b plus ribavirin therapy are associated with therapeutic efficacy in patients with genotype 1b chronic hepatitis C

By                                                  

International Journal of Molecular Medicine, Vol. 30, Iss. 5, 2012-01 ,pp. : 1048-1052

Spandidos Publications

Access to resources Recommend Favorite

Eicosapentaenoic Acid Supplementation for Chronic Hepatitis C Patients During Combination Therapy of Pegylated Interferon α-2b and Ribavirin

By Kawashima Aiko  

Lipids, Vol. 43, Iss. 4, 2008-04 ,pp. : 325-333

Springer Publishing Company

Access to resources Recommend Favorite

Pegylated Interferon α-2b, Ribavirin and Amantadine for Chronic Hepatitis C

By Younossi Zobair   McCullough Arthur   Barnes David   Post Anthony   Ong Janus   O’shea Robert   Martin Lisa   Bringman Diane   Farmer Denise   Levinthal Gavin   Mullen Kevin   Carey William   Tavill Anthony   Ferguson Roy   Gramlich Terry  

Digestive Diseases and Sciences, Vol. 50, Iss. 5, 2005-05 ,pp. : 970-975

Springer Publishing Company

Access to resources Recommend Favorite

Resveratrol in Hepatitis C Patients Treated with Pegylated-Interferon-α-2b and Ribavirin Reduces Sleep Disturbance

By Pennisi Manuela   Bertino Gaetano   Gagliano Caterina   Malaguarnera Michele   Bella Rita   Borzì Antonio Maria   Madeddu Roberto   Drago Filippo   Malaguarnera Giulia  

Nutrients, Vol. 9, Iss. 8, 2017-08 ,pp. : 897-897

MDPI

Access to resources Recommend Favorite

The hepatitis C virus NS5A protein and response to interferon α: mutational analyses in patients with chronic HCV genotype 3a infection from India

By Goyal Ankur   Hofmann Wolf   Hermann Eva   Traver Stella   Hissar Syed   Arora Naveen   Blum Hubert   Zeuzem Stefan   Sarrazin Christoph   Sarin Shiv  

Medical Microbiology and Immunology, Vol. 196, Iss. 1, 2007-03 ,pp. : 11-21

Springer Publishing Company

Access to resources Recommend Favorite